{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:53:13Z","timestamp":1793328793426,"version":"4.5.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec id=\"ab-ioi230069-4\"><jats:title>Importance<\/jats:title><jats:p>Thyroid hormone is among the most common prescriptions in the US and up to 20% may be overtreated. Endogenous hyperthyroidism may be a risk factor for dementia, but data are limited for iatrogenic thyrotoxicosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-5\"><jats:title>Objective<\/jats:title><jats:p>To determine whether thyrotoxicosis, both endogenous and exogenous, is associated with increased risk of cognitive disorders.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study performed a longitudinal time-varying analysis of electronic health records for patients receiving primary care in the Johns Hopkins Community Physicians Network between January 1, 2014, and May 6, 2023. Patients 65 years and older with at least 2 visits 30 days apart to their primary care physicians were eligible. None of the 65\u202f931 included patients had a history of low thyrotropin (TSH) level or cognitive disorder diagnoses within 6 months of their first visit. Data analysis was performed from January 1 through August 5, 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-7\"><jats:title>Exposure<\/jats:title><jats:p>The exposure variable was a low TSH level, characterized based on the clinical context as due to endogenous thyrotoxicosis, exogenous thyrotoxicosis, or unknown cause, excluding those attributable to acute illness or other medical factors such as medications.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The outcome measure was cognitive disorders, including mild cognitive impairment and all-cause dementia, to improve sensitivity and account for the underdiagnosis of dementia in primary care.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-9\"><jats:title>Results<\/jats:title><jats:p>A total of 65\u202f931 patients were included in the analysis (median [IQR] age at first visit, 68.0 [65.0-74.0] years; 37\u202f208 [56%] were female; 46\u202f106 [69.9%] were White). Patients exposed to thyrotoxicosis had cognitive disorder incidence of 11.0% (95% CI, 8.4%-14.2%) by age 75 years vs 6.4% (95% CI, 6.0%-6.8%) for those not exposed. After adjustment, all-cause thyrotoxicosis was significantly associated with risk of cognitive disorder diagnosis (adjusted hazard ratio, 1.39; 95% CI, 1.18-1.64; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) across age groups. When stratified by cause and severity, exogenous thyrotoxicosis remained a significant risk factor (adjusted hazard ratio, 1.34; 95% CI, 1.10-1.63; <jats:italic>P<\/jats:italic>\u2009=\u2009.003) with point estimates suggestive of a dose response.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ioi230069-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study among patients 65 years and older, a low TSH level from either endogenous or exogenous thyrotoxicosis was associated with higher risk of incident cognitive disorder. Iatrogenic thyrotoxicosis is a common result of thyroid hormone therapy. With thyroid hormone among the most common prescriptions in the US, understanding the negative effects of overtreatment is critical to help guide prescribing practice.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2023.5619","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:01:00Z","timestamp":1698073260000},"page":"1324","source":"Crossref","is-referenced-by-count":39,"title":["Endogenous and Exogenous Thyrotoxicosis and Risk of Incident Cognitive Disorders in Older Adults"],"prefix":"10.1001","volume":"183","author":[{"given":"Roy","family":"Adams","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther S.","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Yasar","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Mammen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"ioi230069r1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1365-2265.2000.01146.x","article-title":"Subclinical hyperthyroidism and the risk of dementia: the Rotterdam study.","volume":"53","author":"Kalmijn","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"ioi230069r2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","article-title":"The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism.","volume":"96","author":"Vadiveloo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"ioi230069r3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/WNL.0000000000003227","article-title":"Thyroid function and the risk of dementia: the Rotterdam Study.","volume":"87","author":"Chaker","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"ioi230069r4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/cen.2017.87.issue-5","article-title":"The association between subclinical thyroid dysfunction and dementia: the Health, Aging and Body Composition (Health ABC) Study.","volume":"87","author":"Aubert","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"ioi230069r5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/thy.2019.0672","article-title":"Graves\u2019 disease and toxic nodular goiter, aggravated by duration of hyperthyroidism, are associated with Alzheimer\u2019s and vascular dementia: a registry-based long-term follow-up of two large cohorts.","volume":"30","author":"Folkestad","year":"2020","journal-title":"Thyroid"},{"issue":"12","key":"ioi230069r6","doi-asserted-by":"publisher","first-page":"E2230","DOI":"10.1210\/jc.2012-2108","article-title":"Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study.","volume":"97","author":"Yeap","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ioi230069r7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.neurobiolaging.2007.07.019","article-title":"Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study.","volume":"30","author":"de Jong","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ioi230069r8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.14740\/jem588","article-title":"Association between thyroid dysfunction and incident dementia in the Atherosclerosis Risk in Communities Neurocognitive Study.","volume":"9","author":"George","year":"2019","journal-title":"J Endocrinol Metab"},{"issue":"12","key":"ioi230069r9","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1210\/jc.2016-2129","article-title":"Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies.","volume":"101","author":"Rieben","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ioi230069r10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamainternmed.2021.5078","article-title":"Association of thyroid dysfunction with cognitive function: an individual participant data analysis.","volume":"181","author":"van Vliet","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"10","key":"ioi230069r11","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1210\/jc.2013-4454","article-title":"The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma.","volume":"99","author":"Moon","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"ioi230069r12","first-page":"760","article-title":"Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma.","volume":"35","author":"Jaracz","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"ioi230069r13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11606-018-4377-y","article-title":"Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults.","volume":"33","author":"Amjad","year":"2018","journal-title":"J Gen Intern Med"},{"key":"ioi230069r14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coemr.2019.04.001","article-title":"Interpreting elevated TSH in older adults.","volume":"5","author":"Mammen","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"17","key":"ioi230069r16","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012.","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"ioi230069r17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"ioi230069r18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study.","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"11","key":"ioi230069r19","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1111\/jgs.v70.11","article-title":"Thyroid hormone use and overuse in dementia: results from the Health, Aging and Body Composition Study.","volume":"70","author":"Abbey","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"ioi230069r20","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1210\/jc.2011-3047","article-title":"The natural history of subclinical hypothyroidism in the elderly: the Cardiovascular Health Study.","volume":"97","author":"Somwaru","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ioi230069r21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1089\/thy.2017.0211","article-title":"Unstable thyroid function in older adults is caused by alterations in both thyroid and pituitary physiology and is associated with increased mortality.","volume":"27","author":"Mammen","year":"2017","journal-title":"Thyroid"},{"issue":"1","key":"ioi230069r22","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.v6.1","article-title":"Cohort discovery and risk stratification for Alzheimer\u2019s disease: an electronic health record-based approach.","volume":"6","author":"Tjandra","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"issue":"12","key":"ioi230069r23","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1089\/thy.2021.0321","article-title":"Thyroid function and the risk of Alzheimer\u2019s disease: a Mendelian randomization study.","volume":"31","author":"Marouli","year":"2021","journal-title":"Thyroid"},{"issue":"12","key":"ioi230069r24","doi-asserted-by":"publisher","first-page":"e5064","DOI":"10.1210\/clinem\/dgab527","article-title":"Genetically determined TSH level within reference range is inversely associated with Alzheimer disease.","volume":"106","author":"Li","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ioi230069r25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"ioi230069r26","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"ioi230069r15","unstructured":"ClinCalc DrugStats Database. Accessed September 18, 2023. https:\/\/clincalc.com\/DrugStats\/Default.aspx"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2811088\/jamainternal_adams_2023_oi_230069_1701463564.40187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T16:01:57Z","timestamp":1701705717000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2811088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2023.5619","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}